https://www.selleckchem.com/products/nu7026.html
This study aims to evaluate the safety and efficacy of fluorodeoxyglucose positron emission tomography/computed tomography ( F-FDG-PET/CT) guided intensity-modulated radiation therapy (IMRT) for patients with peritoneal metastases. A total of 55 patients with peritoneal metastases were treated with 18F-FDG-PET/CT-guided IMRT (BIMRT) from January 2012 to January 2019. They were prescribed with a fraction of the median dose of 2 Gy to a total dose of 50.4 Gy. The multivariate analysis was used the Cox proportional hazard model and the Kapl
Like
Comment
Share
